
The IPO season rolls on, and this time it’s Indogulf Cropsciences in the spotlight. But while some recent issues set the grey market buzzing, Indogulf’s IPO is getting a cooler reception. With a GMP (grey market premium) hovering around Rs 17, listing-day fireworks may not be on the cards.
What’s happening?
Indogulf Cropsciences, an agrochemical player with roots going back to 1993, hit the market with a Rs 200 crore IPO. The price band? Rs 105–110 per share. The issue included a fresh offer of Rs 160 crore and an OFS worth Rs 40 crore.
The response? Fairly average. By the end of the final bidding day, the IPO was subscribed just under 1x overall, with retail investors showing the most enthusiasm at around 1.5x. QIBs barely moved the needle, while non-institutional investors (NIIs) also kept their powder dry.
About the company
Indogulf makes crop protection chemicals, micronutrients and biostimulants. It runs four plants across Haryana and Jammu & Kashmir, with a footprint spanning 22 states in India and exports to 34 countries. The company leans on its own R&D, backward integration and a strong distribution network to stay competitive in a cyclical industry.
What it means for investors
The lukewarm GMP suggests that listing gains, if any, could be mild. For long-term investors, Indogulf offers exposure to the agri-chem sector, backed by steady financials and decent export traction. That said, valuations are not exactly cheap, and the sector’s cyclical nature could throw up challenges if input costs rise or rural demand weakens.
Serious about wealth? So are we.
Join thousands of smart investors who rely on Value Research Stock Advisor for expert-picked stocks, time-tested strategies and long-term discipline.
Stop guessing. Start growing. Check it out now: Value Research Stock Advisor.
Disclaimer: This is not a stock recommendation. This story was created with the assistance of artificial intelligence and is intended for informational purposes only. Please take it with a pinch of salt and do your own research or consult a financial advisor before making investment decisions.






